1. Home
  2. WHG vs MIST Comparison

WHG vs MIST Comparison

Compare WHG & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WHG
  • MIST
  • Stock Information
  • Founded
  • WHG 1983
  • MIST 2003
  • Country
  • WHG United States
  • MIST Canada
  • Employees
  • WHG N/A
  • MIST N/A
  • Industry
  • WHG Investment Managers
  • MIST Biotechnology: Pharmaceutical Preparations
  • Sector
  • WHG Finance
  • MIST Health Care
  • Exchange
  • WHG Nasdaq
  • MIST Nasdaq
  • Market Cap
  • WHG 151.0M
  • MIST 145.3M
  • IPO Year
  • WHG 2002
  • MIST N/A
  • Fundamental
  • Price
  • WHG $17.22
  • MIST $1.97
  • Analyst Decision
  • WHG
  • MIST Strong Buy
  • Analyst Count
  • WHG 0
  • MIST 3
  • Target Price
  • WHG N/A
  • MIST $6.33
  • AVG Volume (30 Days)
  • WHG 8.9K
  • MIST 1.2M
  • Earning Date
  • WHG 10-29-2025
  • MIST 11-11-2025
  • Dividend Yield
  • WHG 3.49%
  • MIST N/A
  • EPS Growth
  • WHG N/A
  • MIST N/A
  • EPS
  • WHG 0.42
  • MIST N/A
  • Revenue
  • WHG $95,673,000.00
  • MIST N/A
  • Revenue This Year
  • WHG N/A
  • MIST N/A
  • Revenue Next Year
  • WHG N/A
  • MIST N/A
  • P/E Ratio
  • WHG $40.89
  • MIST N/A
  • Revenue Growth
  • WHG 5.68
  • MIST N/A
  • 52 Week Low
  • WHG $12.47
  • MIST $0.63
  • 52 Week High
  • WHG $18.97
  • MIST $2.75
  • Technical
  • Relative Strength Index (RSI)
  • WHG 46.48
  • MIST 67.34
  • Support Level
  • WHG $17.06
  • MIST $1.75
  • Resistance Level
  • WHG $17.44
  • MIST $1.83
  • Average True Range (ATR)
  • WHG 0.42
  • MIST 0.09
  • MACD
  • WHG -0.10
  • MIST 0.02
  • Stochastic Oscillator
  • WHG 23.34
  • MIST 79.49

About WHG Westwood Holdings Group Inc

Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: